In summary, excessive hepatic glucose and fructose metabolism also drives insulin resistance through glycolytic overload-linked pathways: hexosamine pathway—stabilizing GCK and ChREBP to proteolysis, the latter suppressing expression of IRS-2; and increased MG with activation of the UPR. The gene discussed is GCK; the disease is Insulin resistance.